Cargando…
Prognostic Factors in Advanced Adrenocortical Carcinoma: Summary of a National Referral Center’s 20 years of Experience
CONTEXT: Adrenocortical carcinoma (ACC) is a rare malignancy with poor prognosis for both locally advanced and metastatic disease. Standard treatment with combination etoposide–doxorubicin–cisplatin–mitotane (EDP-M) is highly toxic and some patients benefit from mitotane monotherapy. However, identi...
Autores principales: | Arnon, Johnathan, Grozinsky-Glasberg, Simona, Oleinikov, Kira, Gross, David J, Salmon, Asher, Meirovitz, Amichay, Maimon, Ofra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354968/ https://www.ncbi.nlm.nih.gov/pubmed/35949453 http://dx.doi.org/10.1210/jendso/bvac112 |
Ejemplares similares
-
Dosimetry after peptide receptor radionuclide therapy: impact of reduced number of post-treatment studies on absorbed dose calculation and on patient management
por: Chicheportiche, Alexandre, et al.
Publicado: (2020) -
Can a penalized-likelihood estimation algorithm be used to reduce the injected dose or the acquisition time in (68)Ga-DOTATATE PET/CT studies?
por: Chicheportiche, Alexandre, et al.
Publicado: (2021) -
Predictive power of the post-treatment scans after the initial or first two courses of [(177)Lu]-DOTA-TATE
por: Chicheportiche, Alexandre, et al.
Publicado: (2018) -
Calcitonin Non-Secreting Mixed Medullary-Papillary Thyroid Carcinoma: Report of a Rare Entity and Therapeutic Implications
por: Oleinikov, Kira, et al.
Publicado: (2021) -
Simple model for estimation of absorbed dose by organs and tumors after PRRT from a single SPECT/CT study
por: Chicheportiche, Alexandre, et al.
Publicado: (2021)